I have some questions regarding how to interpret Drug sensitivity AUC and Logfold change value during compound screening on cell lines:
If cell line A has the higher the drug sensitivity AUC than cell line B on compound C, does it mean that cell line A is more sensitive than cell line B when treated with compound C?
If cell line A has positive higher logfold change value than cell line B on compound C, does it mean that cell line A is more resistant than cell line B when treated with compound C? How about if cell line A has negative logfold change, what does it mean again?
Higher AUC implies less sensitivity to the compound, similarly higher LFC also implies less sensitivity.
As a reasonable heuristic, you can consider AUC as the average of 2^LFC (i.e. foldchange viabilities) over different doses, so they are (roughly) increase and decrease together.
I want to learn about the first question of @Marissa
My understanding is
“if cell line A has a higher drug sensitivity AUC (Area Under the Curve) than cell line B when treated with compound C, it means that cell line A is more sensitive to the effects of compound C compared to cell line B.” I thought higher AUC correlates with a stronger or more significant response to compound C? Best,
Amare
Hi, is it expected that the auc values are quite often above 1.0? I am working on the “secondary-screen-dose-response-curve-parameters.csv” and 32% of values are above 1.0.
Dear Mustafa_Kocak:
Is an AUC value greater than 1 meaningful? Can it be used for deep learning modeling? Because I believe an AUC value greater than 1 suggests that the drug cannot inhibit the corresponding cell line.